Vital signs alert could save lives in blood cancer care
NCT ID NCT06409767
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether using a simple early warning score (NEWS) to quickly move high-risk blood cancer patients to the ICU can reduce deaths and organ failure. Over 2,200 adults receiving intensive chemotherapy or stem cell transplants will take part across ten hospitals. Half the hospitals will use the warning system; the other half will continue usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- National Early Warning Score (NEWS) monitoring with ICU referral
- What this could lead to
- If it works, this could show that closely monitoring vital signs and acting early saves more lives in blood cancer patients undergoing intensive treatment.
- What could go wrong
- This is a large trial but it tests a monitoring strategy, not a new drug. The benefit may be small, and early ICU admission could increase anxiety and resource use without improving survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Amiens-Picardie
RECRUITINGAmiens, 80054, France
-
Centre Hospitalier Universitaire Besancon
RECRUITINGBesançon, 25030, France
-
Centre Hospitalier Universitaire Brest
RECRUITINGBrest, 29609, France
-
Centre Hospitalier Universitaire Nantes
RECRUITINGNantes, 44093, France
-
Centre Hospitalier Universitaire d'Angers
RECRUITINGAngers, 49933, France
-
Centre Hospitalier Universitaire poitiers
RECRUITINGPoitiers, 86021, France
-
Centre Hospitalier universitaire Nancy
RECRUITINGNancy, 45011, France
-
centre Hospitalier Universitaire Saint etienne
RECRUITINGSaint-Etienne, 42270, France
-
centre Hospitalier Universitaire Strasbourg
NOT_YET_RECRUITINGStrasbourg, 67098, France
-
centre Hospitalier Universitaire Tours
RECRUITINGTours, 37044, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill keep blood cancer at bay after a stem cell transplant?
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Tumor's DNA guide better cancer care for kids?
- Can a modified enzyme starve Hard-to-Treat blood cancers?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?